Novel formulation for oral administration, comprising 1-(5-(2,4-difluorophenyl)-1-( (3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine
IR114330BUndetermined Publication Date: 2026-08-23DAEWOONG PHARM CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- IR140250140003002021
- Authority / Receiving Office
- IR · IR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-06-17
- Publication Date
- 2026-08-23
- Estimated Expiration
- 2043-06-17
Need to check novelty before this filing date? Find Prior Art
No text content released.